BTG3 and preeclampsia: Multivariate regression analysis, adjusting for demographic information, clinical characteristic factors, and concomitant medication use, showed that HCQ significantly reduced the incidence of preeclampsia in both ANA-positive and ANA-weakly positive groups, significantly prolonged gestation weeks in the ANA-positive group, and significantly reduced the incidence of SGA in the ANA-weakly positive group.